ArticleTranslational lung cancer research2022

Erratum to identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance.

Editorial OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.